Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 17, 2026
Can you apply?
This grant is for early-career researchers pursuing novel genomics research with potential clinical applications. Applicants must have an MD, PhD, or equivalent doctoral degree and typically be within 5-10 years of their terminal degree, with limited prior NIH R01 funding. Both for-profit and nonprofit research institutions, universities, colleges, and eligible medical schools may apply. Research may include human subjects and clinical trials are optional. The program supports independent research projects that demonstrate innovation in genomic science and has no geographic restrictions beyond standard NIH requirements. Early-career investigators should have demonstrated research productivity but may have had mentored K awards or early independence awards (K99/R00) to qualify.
Not the right fit? Find grants for your organization in 5 questions →
Program description
This Funding Opportunity Announcement is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative research in genomics. This opportunity is open to research in all areas relevant to the mission of NHGRI, including genomic sciences, genomic medicine, genomic data science, and ethical, legal, and social implications of genomics.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH Form SF-424 (R&R) and R&R Subaward Budget Attachment Form
- Project Narrative (Research Strategy) including Specific Aims, Research Design and Methods, and expected outcomes
- Preliminary Studies and Progress Report (for prior NIH support)
- Bibliography and References Cited
- Biographical Sketches of all key personnel (NIH Form Page 5)
- Detailed Budget and Budget Justification
- Current and Pending Support documentation
- Institutional Commitment and Resources letter from institution/department
- Vertebrate Animals or Human Subjects Protections documentation (if applicable)
- Data Management and Sharing Plan
- Facilities and Administrative (F&A) or Facilities and Cost Share documentation
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.172 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$39,531,110
-
$34,574,245
-
$32,186,204
-
$30,195,606
-
$26,495,937
-
$26,020,371
-
$24,964,130
-
$24,413,854
-
$23,757,911
-
$22,977,417
Top States by Funding
- CA 19 awards $317.2M
- MA 16 awards $302.5M
- WA 9 awards $140.1M
- NY 6 awards $93.6M
- NC 5 awards $93.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.172). How funding has trended year over year.
| 2024 | $452,727,668 | |
| 2025 | $423,878,429 | |
| 2026 est. | $9,989,158 |
FAQ
Who is considered an "early-career researcher" for this R01 grant?
Typically, researchers within 5-10 years of their terminal degree (MD, PhD, DDS, DVM, or equivalent) who have limited prior R01 funding. Some researchers with K99/R00 awards or postdoctoral fellowship support may also qualify. Check NIH's specific definition for this funding opportunity.
What research topics are eligible?
Novel genomics research is supported, including basic, translational, and clinical genomics. Clinical trials are optional, allowing flexibility for basic science projects. Research must align with NIH's mission to advance biomedical science.
What is the typical funding range and project period?
R01 grants typically fund $100,000–$500,000+ annually depending on the research scope and institution. Project periods are commonly 3–5 years. Consult the specific FOA (Funding Opportunity Announcement) for exact ranges.
When are the submission deadlines?
This opportunity has a fixed deadline of February 26, 2027. Standard NIH submission windows typically allow applications 30 days before the deadline. Check NIH eRA Commons for exact cutoff dates.
How competitive is this grant?
R01 grants are highly competitive, with success rates typically 15–25% across NIH. Genomics is an active research area. Strong preliminary data, clear innovation, and a track record of productivity are essential to be competitive.
💡 Tips for applicants
- Demonstrate innovation in genomic methodology or discovery. Reviewers want to see novel approaches, not incremental advances. Strong preliminary data showing feasibility is critical for early-career researchers with limited R01 experience.
- Build a credible research team with complementary expertise. Early-career investigators should identify experienced collaborators to strengthen applications, especially if this is your first R01. Avoid gaps in statistical, bioinformatic, or clinical expertise.
- Align your research with NIH priorities and the specific genomics focus areas. Consult NINDS, NHGRI, NHLBI, or other relevant institute guidelines and recent funded portfolios to ensure your project fits institutional priorities.
- Create a detailed, realistic budget and timeline with clear milestones. Break down research aims into specific, measurable objectives with interim checkpoints. Overly ambitious or vague aims will weaken your competitiveness.
- Address potential scientific weaknesses or gaps preemptively in your research strategy. If your preliminary data is limited, explain your plan to strengthen it. Reviewers respect thoughtful risk assessment and mitigation over overconfident claims.
⚠️ Common mistakes
Many early-career R01 applications fail because the research aims are too broad or lack sufficient preliminary data to demonstrate feasibility. Reviewers expect independent researchers to have moved beyond their postdoctoral training and show evidence of developing their own research program. Additionally, weak or missing bioinformatic and statistical plans are common pitfalls in genomics proposals; ensure you have co-investigators with genuine expertise in these areas, not just listed collaborators. Finally, poor alignment with specific NIH institute priorities or failure to address how your work advances the field beyond existing literature will result in lower scores.
Similar grants
- OPEN GREGoRi Innovation Projects (U01 Clinical Trial Optional) — National Institutes of Health
- OPEN Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Mentored Research Scientist Development Award (Parent K01 – Independent Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) — National Institutes of Health